Renaissance Investment Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-4,051
Closed -$229K – 79
2023
Q2
$229K Buy
4,051
+330
+9% +$18.2K 0.06% 76
2023
Q1
$201K Buy
+3,721
New +$198K 0.06% 81
2022
Q2
– Sell
-3,661
Closed -$201K – 83
2022
Q1
$201K Sell
3,661
-308
-8% -$18.4K 0.06% 82
2021
Q4
$261K Sell
3,969
-71
-2% -$4.54K 0.06% 74
2021
Q3
$254K Sell
4,040
-214
-5% -$13.7K 0.06% 72
2021
Q2
$256K Buy
4,254
+48
+1% +$2.78K 0.07% 75
2021
Q1
$232K Sell
4,206
-198
-4% -$11K 0.06% 77
2020
Q4
$240K Sell
4,404
-642
-13% -$33.6K 0.07% 79
2020
Q3
$252K Sell
5,046
-312
-6% -$15.1K 0.08% 72
2020
Q2
$236K Buy
+5,358
New +$229K 0.09% 70
2020
Q1
– Sell
-4,734
Closed -$209K – 76
2019
Q4
$209K Buy
+4,734
New +$199K 0.07% 78

Other funds holding IHI

Renaissance Investment Group's IHI Position: Q3 2023 in Review

Renaissance Investment Group sold out of iShares US Medical Devices ETF (IHI) in Q3 2023, closing a stake of 4,051 shares — an estimated $229K sold.

Renaissance Investment Group first reported a position in IHI in Q4 2019 and held it in 11 quarters. The position peaked at $261K in Q4 2021. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Renaissance Investment Group reported no remaining iShares US Medical Devices ETF position as of Q3 2023 after selling out during the quarter.
  • Renaissance Investment Group sold 4,051 iShares US Medical Devices ETF shares in Q3 2023, an estimated $229K.
  • Renaissance Investment Group first reported a position in iShares US Medical Devices ETF in Q4 2019 and held it in 11 quarters.
  • Renaissance Investment Group's iShares US Medical Devices ETF position peaked at $261K in Q4 2021.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Renaissance Investment Group's 13F filing for Q3 2023, filed 10 Oct 2023.